Lynparza (olaparib) was granted approval by the Food and Drug Administration (FDA) for the treatment of patients with BRCA-positive, HER2-negative metastatic breast cancer who have previously received chemotherapy. Also, patients who have HR-positive disease should have prior endocrine therapy or they would not be considered appropriate for such treatment.
"Garden variety" breast cancer is no longer the norm thanks to the discovery of more genetic mutations.
Those of us who had chemotherapy and/or radiation as part of our treatment have now been hit with another lovely late effect, if the results of a new study are accurate. We have the potential to age prematurely.
Lymphedema requires diligence all seasons. Do not let icy cold weather catch you or your lymphedema, unaware. Take precautions to protect yourself.
The after effects of breast cancer can leave survivors wondering how much more medical trauma they can take. The daily struggle presents challenges for many survivors. This is one survivor's story.
There is magic in the realization that the best of humanity is lifting you up, praying for you, holding you close, reaching out and touching your life in whatever way they can.
Don't be ashamed that you haven't "moved on," says this metastatic breast cancer patient.
New discoveries happen often. Is there one for us?
Breast cancer and melanoma survivor reflects about being tired of her cancers and shares a way to respond to uncertainty.
Fat cells can harbor extra estrogen. With this in mind, doesn't it make sense for women affected by estrogen-fed cancer to become conscious of their weight?
Kisqali (ribociclib) was granted a breakthrough therapy designation by the Food and Drug Administration (FDA) to be used in combination with tamoxifen or an aromatase inhibitor (AI) in the frontline treatment of pre- or perimenopausal women who have hormone receptor-positive HER2-negative advanced or metastatic breast cancer.
Most Americans have insurance. We find comfort in knowing our future is secure in the event of a health crisis. But how do we know how much insurance is enough? Is it wise to take our specialized policies?
Breast cancer, melanoma survivor and clutter-clearing speaker/author clears her cancer and household clutter.
It is hard to start a new year in the middle of cancer treatment. That was the situation for me, and I recall grasping at anything positive I could find in the coming of a new year.
A poem reflecting on one survivor's feelings on bras.